Xiaohan Chi's Homepage

MD Anderson Cancer Center

Welcome to my homepage! I am a third-year PhD candidate in the Department of Biostatistics at The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), co-advised by Dr. Ruitao Lin and Dr. Ying Yuan. Before joining MD Anderson, I obtained both my MS and BS degrees from Shanghai Jiao Tong University (SJTU), advised by Dr. Zhangsheng Yu.

My current research interests lie in Bayesian clinical trial design, covariate adjustment and causal inference.

MS, Shanghai Jiao Tong University, 2022
BS, Shanghai Jiao Tong University, 2019

  1. Chi, X., Yu, Z., and Lin, R. (2022). BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints. Statistics in Medicine. 41(26): 5319 – 5334.
  2. Chi, X., Yuan, Y., Yu, Z., and Lin, R. (2024). A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints. Biometrical Journal. 66(2): 2300122.
  3. Dasgupta, P., Dagher, S., Chi, X., Soomro, Z., Wathoo, C., Lin, R., Wintermark, M., Chen, M., Puduvalli, V. K., and Majd, N. K. (2024). Biom-32. Genomic determinants of diffusely infiltrative gliomatosis cerebri pattern. Neuro-Oncology. 26(Supplement_8): viii26.

  1. Second Place of 2023 JSM Biopharmaceutical Student Paper Awards.
    Awarded project: the Generalized Calibrated Bayesian Hierarchical Modeling Approach (GCBHM).
  2. Honorable Mention Winner of 2022 JSM Biopharmaceutical Student Paper Awards.
    Awarded project: the Bayesian Optimal Design for Biosimilar Trials (BOB).
0%